Andrea Roe
Andrea Roe
Assistant Professor of Obstetrics and Gynecology at the Pennsylvania Hospital
Attending Physician, Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending Physician, Penn Medicine Pregnancy Early Access Center (PEACE), Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Attending Physician, Penn Medicine Pregnancy Early Access Center (PEACE), Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Co-Director, Obstetrics and Gynecology Clerkship, University of Pennsylvania Perelman School of Medicine
Department: Obstetrics and Gynecology
Contact information
3737 Market Street
PEACE - 12th floor
Philadelphia, PA 19104
PEACE - 12th floor
Philadelphia, PA 19104
Email:
andrea.roe@uphs.upenn.edu
andrea.roe@uphs.upenn.edu
Education:
BA
Harvard College, 2003.
MD
University of Pennsylvania School of Medicine, 2011.
MPH
Harvard School of Public Health, 2016.
BA
Harvard College, 2003.
MD
University of Pennsylvania School of Medicine, 2011.
MPH
Harvard School of Public Health, 2016.
Post-Graduate Training
Resident in Obstetrics and Gynecology, Hospital of the University of Pennsylvania, 2011-2015.
Fellow in Family Planning, Brigham and Women's Hospital, 2015-2017.
Permanent linkResident in Obstetrics and Gynecology, Hospital of the University of Pennsylvania, 2011-2015.
Fellow in Family Planning, Brigham and Women's Hospital, 2015-2017.
Selected Publications
Godfrey EM, Magaret A, Roe A, Taylor-Cousar JL, Walker P, Langfelder-Schwind E, Kazmerski TM, Jain R, Mody SK, Uluer A, West NE, Bray LA, Hsu C, Fiastro A, Stukovsky KDH, Hadjiliadis D, Solomon GM, Ladores-Barrett S.: Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers. J Cyst Fibros Jan 2025.Creinin MD, Gawron LM, Roe AH, Blumenthal PD, Boraas CM, Hou MY, McNicholas C, Schreifels MJ, Peters K, Culwell K, Turok DK; Copper 175mm(2) IUD Phase 3 Clinical Investigator Group.: Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device. Contraception 2025.
Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, West NE, Kazmerski TM, Goralski JL, Flume PA, Roe AH, Hadjiliadis D, Uluer A, Mody S, Ladores S, Taylor-Cousar JL.: Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy. Chest 2025.
O'Brien SH, Stanek JR, House A, Cronin RM, Creary SE, Roe AH, Vesely SK.: Trends in Pregnancy Outcomes in People with Sickle Cell Disease and Medicaid Insurance (2006-2018). J Womens Health (Larchmt) 2025.
Lee IT, Wu J, Koelper N, Mumford SL, Barnhart KT, Roe AH.: Prediction of menstrual cycle phase using cross-sectional measurements of reproductive hormones. Fertil Steril 2025.
Roe AH, Wu J, McAllister A, Aragoncillo S, Nunyi E, Voltaire S, Pishko A, Sayani F, Cebert M: Contraceptive Attitudes and Beliefs of Women With Sickle Cell Disease: A Qualitative Study. Womens Health Issues 34(4):409-416, Jul-Aug 2024.
Hoffman EA, Kaufman J, Koelper NC, Sonalkar S, Roe AH: Outcomes After Induction of Labor Compared With Dilation and Evacuation for the Management of Rupture of Membranes in the Second Trimester. Obstet Gynecol 143: 550-553, Apr 2024.
Chesnokova AE, Nagendra D, Dixit E, McAllister A, Schachter A, Schreiber CA, Roe AH, Sonalkar S: Trust in provider and stigma during second-trimester abortion. Sex Reprod Healthc 39:100932, Mar 2024.
Wu JK, McVay K, Mahoney KM, Sayani FA, Roe AH, Cebert M.: Experiences with healthcare navigation and bias among adult women with sickle cell disease: a qualitative study. Qual Life Res 2024.
Chen J, Nijim S, Koelper N, Flynn AN, Sonalkar S, Schreiber CA, Roe AH.: Telemedicine Follow-up After Medication Management of Early Pregnancy Loss. J Womens Health (Larchmt) 2024.